References
- Matsushita H, Tanaka S, Saiki Y, Hara M, Nakata K, Tanimura S, et al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995;45:925-32 https://doi.org/10.1111/j.1440-1827.1995.tb03417.x
- Park J, Kim DS, Shim TS, Lim CM, Koh Y, Lee SD, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001;17:1216-9 https://doi.org/10.1183/09031936.01.99055301
- Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005;11:431-7 https://doi.org/10.1097/01.mcp.0000170521.71497.ba
- Yamadori I, Sato T, Fujita J, Dobashi N, Ohtsuki Y, Takahara J. A case of non-specific interstitial pneumonia associated with primary lung cancer: possible role of antibodies to lung cancer cells in the pathogenesis of non-specific interstitial pneumonia. Respir Med 1999;93:754-6 https://doi.org/10.1016/S0954-6111(99)90045-8
- Sato T, Yamadori I, Fujita J, Hamada N, Yonei T, Bandoh S, et al. Three cases of non-specific interstitial pneumonia associated with primary lung cancer. Intern Med 2004;43:721-6 https://doi.org/10.2169/internalmedicine.43.721
- Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47 https://doi.org/10.1097/00000478-199402000-00003
- Reyes LJ, Morell F, Xaubet A, Ramirez J, Majo J. Nonspecific interstitial pneumonia: epidemiologic and clinical characteristics. Med Clin 2006;126:47-52
- Patel AM, Davila DG, Peters SG. Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 1993;68:278-87
- Bandoh S, Fujita J, Haba R, Tojo Y, Horiike A, Okamoto T, et al. Lung cancer with focal lymphocytic interstitial pneumonia. Intern Med 2002;41:997-1001 https://doi.org/10.2169/internalmedicine.41.997
- Takanami I, Takeuchi K, Giga M The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 2001;121:1058-63 https://doi.org/10.1067/mtc.2001.113026
- Lee TK, Horner RD, Silverman JF, Chen YH, Jenny C, Searantino CW. Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer 1989;63:300-16
- Lipford EH 3rd, Eggleston JC, Lillemoe KD, Sears DL, Moore GW, Baker RR. Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung. Am J Surg Pathol 1984;8:357-65 https://doi.org/10.1097/00000478-198405000-00004
- Brittenden J, Beys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996;77:1226-43 https://doi.org/10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G
- Johnson SK, Kerr KM, Chapman AD, Kennedy MM, King G, Cockburn JS, et al. Immune cell infiltrates and prognosisin primary carcinoma of the lung. Lung Cancer 2000;27:27-35 https://doi.org/10.1016/S0169-5002(99)00095-1
- Watanabe S, Sato Y, Kodama T, Shimosato Y. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancers. Cancer Res 1983;43:5883-9